Hungree Syrup contains Cyproheptadine at a concentration of 2 mg per 5 ml and is primarily indicated as an appetite stimulant in patients experiencing inadequate nutritional intake due to various medical conditions. Cyproheptadine is a first-generation antihistamine with additional antiserotonergic properties, which contribute to its efficacy in enhancing appetite and promoting weight gain. This medication is commonly prescribed for individuals suffering from anorexia, cachexia, or other conditions associated with poor appetite, including chronic illnesses and certain psychiatric disorders. Hungree Syrup acts by blocking histamine H1 receptors and serotonin receptors in the central nervous system, thereby increasing the sensation of hunger and improving overall food intake. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on patient age, weight, and clinical response, with careful monitoring for potential side effects such as drowsiness, dry mouth, dizziness, and gastrointestinal disturbances. Caution is advised in patients with a history of glaucoma, asthma, or cardiovascular disease. Hungree Syrup should be used under medical supervision, and it is contraindicated in individuals with hypersensitivity to cyproheptadine or any of its excipients. Regular assessment of therapeutic outcomes and adverse effects is recommended during treatment.